Tonix Pharmaceuticals Holding Corp.

NASDAQ: TNXP
Share price (1/6/25): $0.31
Market cap (1/6/25): $58.4 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 09/30/24 Q3

ended 06/30/24 Q2

Late quarterly filing notification for Q2 2024

ended 03/31/24 Q1

ended 12/31/23 FY 2023

Prospectuses and Registrations Filter

Prospectus supplement for primary offering

Registration of securities for employees

Shelf registration

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Ownership Filter

Sabby Management, LLC

Armistice Capital, LLC

Alyeska Investment Group, L.P.

Empery Asset Management, LP

L1 Capital Global Opportunities Master Fund, Ltd.

News Filter

Announces PDUFA Goal Date of August 15, 2025, for FDA Decision on U.S. Marketing Approval for TNX-102 SL for Fibromyalgia

Other Events, Financial Statements or Exhibits

Announces FDA Acceptance of the New Drug Application (NDA) for TNX-102 SL for Fibromyalgia

Investor Presentation

Announces Expansion of Leadership Team With Two Strategic Hires

Proxies Filter

Definitive proxy

Preliminary proxy

Definitive proxy

Preliminary proxy

Definitive proxy

Other Filter

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Scanned paper annual report submission

Scanned paper annual report submission